ES2074721T3 - Derivados de ciclopentano, procedimientos para su preparacion y su utilizacion farmaceutica. - Google Patents

Derivados de ciclopentano, procedimientos para su preparacion y su utilizacion farmaceutica.

Info

Publication number
ES2074721T3
ES2074721T3 ES91912997T ES91912997T ES2074721T3 ES 2074721 T3 ES2074721 T3 ES 2074721T3 ES 91912997 T ES91912997 T ES 91912997T ES 91912997 T ES91912997 T ES 91912997T ES 2074721 T3 ES2074721 T3 ES 2074721T3
Authority
ES
Spain
Prior art keywords
pharmaceutical use
derivatives
cyclopentan
procedures
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91912997T
Other languages
English (en)
Inventor
Ulrich Dr Klar
Hartmut Dr Rehwinkel
Helmut Prof Vorbruggen
Karl-Heinz Dr Thierauch
Peter Dr Verhallen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2074721T3 publication Critical patent/ES2074721T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A DERIVADOS DEL CICLOPENTANO DE LA FORMULA (I) EN LA QUE HAY UN DOBLE ENLACE ENTRE LOS ATOMOS DE CARBONO DE CENTROS A-B O C-D, Y A SUS SALES CON BASES TOLERABLES FISIOLOGICAMENTE, ASI COMO LOS CICLODEXTRINA CLATRATOS (ALFA), (BETA) O Y, ASI COMO LOS COMPUESTOS ENCAPSULADOS CON LIPOSOMAS DE LA FORMULA (I), PROCESO PARA SU FABRICACION Y SU EMPLEO FARMACEUTICO.
ES91912997T 1990-07-27 1991-07-22 Derivados de ciclopentano, procedimientos para su preparacion y su utilizacion farmaceutica. Expired - Lifetime ES2074721T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4024347A DE4024347A1 (de) 1990-07-27 1990-07-27 Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Publications (1)

Publication Number Publication Date
ES2074721T3 true ES2074721T3 (es) 1995-09-16

Family

ID=6411402

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91912997T Expired - Lifetime ES2074721T3 (es) 1990-07-27 1991-07-22 Derivados de ciclopentano, procedimientos para su preparacion y su utilizacion farmaceutica.

Country Status (13)

Country Link
EP (1) EP0541594B1 (es)
JP (1) JPH06502390A (es)
AT (1) ATE122036T1 (es)
AU (1) AU8221291A (es)
CA (1) CA2088161A1 (es)
DE (3) DE4024347A1 (es)
DK (1) DK0541594T3 (es)
ES (1) ES2074721T3 (es)
IE (1) IE67507B1 (es)
IL (1) IL98970A0 (es)
PT (1) PT98464B (es)
WO (1) WO1992002495A1 (es)
ZA (1) ZA915905B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4036140A1 (de) * 1990-11-09 1992-05-14 Schering Ag 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
DE69809268T2 (de) * 1997-09-09 2003-08-28 Procter & Gamble Aromatische c16-c20-substituierte tetrahydro-prostaglandine und ihre verwendung als prostaglandin f agonisten
DE69832513T2 (de) * 1997-09-09 2006-07-13 Duke University Aromatische c16-c20-substituierte tetrahydro-prostaglandinen verwendbar wie fp agoniste
TR200000671T2 (tr) * 1997-09-09 2000-07-21 The Procter & Gamble Company FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
US6242493B1 (en) 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO1999047497A2 (en) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
MXPA01008955A (es) 1999-03-05 2002-04-24 Procter & Gamble Analogos de prostaglandinas selectivas de fp no saturadas de c16.
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7323591B2 (en) * 2006-01-10 2008-01-29 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
WO2009140205A2 (en) * 2008-05-15 2009-11-19 Allergan, Inc. Therapeutic substituted cyclopentanes
CN106928227B (zh) * 2010-07-15 2020-06-30 浙江奥翔药业股份有限公司 恩替卡韦的合成方法及其中间体化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
IT1053781B (it) * 1974-09-25 1981-10-10 Erba C S P A Ora Farmitalia Omega nor cicloalcil 13.14 deidro prostaglandine
FR2349328A1 (fr) * 1976-04-30 1977-11-25 Roussel Uclaf Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
DE3325175A1 (de) * 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3510978A1 (de) * 1985-03-22 1986-09-25 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 9-halogenprostaglandine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IL87116A (en) * 1987-07-17 1993-03-15 Schering Ag 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same
DE3923797A1 (de) * 1989-07-14 1991-01-24 Schering Ag 9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Also Published As

Publication number Publication date
EP0541594B1 (de) 1995-05-03
AU8221291A (en) 1992-03-02
IE912654A1 (en) 1992-01-29
ZA915905B (en) 1992-04-29
CA2088161A1 (en) 1992-01-28
DE4191848D2 (de) 1993-10-07
EP0541594A1 (de) 1993-05-19
WO1992002495A1 (de) 1992-02-20
PT98464B (pt) 1997-10-31
DK0541594T3 (da) 1995-10-02
JPH06502390A (ja) 1994-03-17
PT98464A (pt) 1992-05-29
DE4024347A1 (de) 1992-01-30
IE67507B1 (en) 1996-04-03
DE59105400D1 (de) 1995-06-08
IL98970A0 (en) 1992-07-15
ATE122036T1 (de) 1995-05-15

Similar Documents

Publication Publication Date Title
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
ES2074721T3 (es) Derivados de ciclopentano, procedimientos para su preparacion y su utilizacion farmaceutica.
CY1110988T1 (el) Ταχεως αποσαθρουμενο στερεο παρασκευασμα
SE9904505D0 (sv) Novel compounds
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
MX9300014A (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion.
ES2141688B1 (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
FR2359830A1 (fr) 6-alcoyl-pyrimidines utilisables comme medicament, notamment contre la malaria
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
BR0111266A (pt) Sìntese reduzida de derivados de 3,3-diarilpropilamina
CY1112050T1 (el) Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
ES2155433T3 (es) Compuestos de 7-acil-3-(carbamoiloxi substituido) cefem, su utilizacion y procedimiento para su fabricacion.
AR014146A1 (es) Compuestos de triazina, su uso en terapia, composiciones farmaceuticas que los contienen, proceso para su manufactura e intermediarios de sintesis
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
EE02942B1 (et) Metüülpiperasinoasepiini derivaadid, nende valmistamine ja kasutamine
ES2141948T3 (es) Derivados de ciclohexanona, procedimiento para su preparacion y productos intermedios del procedimiento.
ES2080956T3 (es) Derivados de ciclopenteno, procedimiento para su obtencion y utilizacion farmaceutica de los mismos.
DE60111634D1 (de) Verfahren zur herstellung von thiazolidinedion-derivaten und zwischenprodukte
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
DK0558570T3 (da) Cyklopentanetherderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
ES2059485T3 (es) Derivados de 2-amino-1,2,3,4-tetrahidroisoquinolina, procedimiento de su preparacion y su aplicacion como medicamento.
PT1097145E (pt) Derivados de poli-hidroxialquilpirazina e sua preparacao e medicamentos que os contem
BR0008798A (pt) L-arabino-dissacarìdeos de antraciclinas,processos para sua preparação e composiçõesfarmacêuticas contendo os mesmos
GT199800008A (es) Procedimiento para la preparacion de un derivado de tetrahidropiridina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 541594

Country of ref document: ES